UPDATE – Aprea Therapeutics presents at the HC Wainwright Annual Global Investment Conference

DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Oren Gilad Ph.D, President and Chief Executive Officer, will be making an in-person presentation at the HC Wainwright 26^and Annual Global Investment Conference, taking place September 9-11, 2024 in New York, NY. Details are as follows:

HC Wainwright 26^and Annual Global Investment Conference